These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3898183)

  • 21. Oral physostigmine and lecithin improve memory in Alzheimer disease.
    Thal LJ; Fuld PA; Masur DM; Sharpless NS
    Ann Neurol; 1983 May; 13(5):491-6. PubMed ID: 6347034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of doses.
    Tariot PN; Sunderland T; Weingartner H; Murphy DL; Cohen MR; Cohen RM
    Arch Gen Psychiatry; 1986 Aug; 43(8):727-32. PubMed ID: 3729666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.
    Grossman F; Okamoto A; Turkoz I; Gharabawi G
    J Am Geriatr Soc; 2004 May; 52(5):852-3. PubMed ID: 15086685
    [No Abstract]   [Full Text] [Related]  

  • 24. Naloxone-methadone combination for the treatment of opiate dependence.
    Parwatikar S; Knowles RR
    Proc Natl Conf Methadone Treat; 1973; 2():1350-4. PubMed ID: 4612373
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of naloxone in neurology].
    Mendel T; Barańska-Gieruszczak M
    Neurol Neurochir Pol; 1988; 22(6):553-7. PubMed ID: 3077436
    [No Abstract]   [Full Text] [Related]  

  • 26. A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease).
    Brinkman SD; Pomara N; Goodnick PJ; Barnett N; Domino EF
    J Clin Psychopharmacol; 1982 Aug; 2(4):281-5. PubMed ID: 7119136
    [No Abstract]   [Full Text] [Related]  

  • 27. Relief of intractable pruritus with naloxone.
    Bernstein JE; Swift R
    Arch Dermatol; 1979 Nov; 115(11):1366-7. PubMed ID: 389168
    [No Abstract]   [Full Text] [Related]  

  • 28. The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride.
    Kurland AA; McCabe OL; Hanlon TE; Sullivan D
    Am J Psychiatry; 1977 Dec; 134(12):1408-10. PubMed ID: 335903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of naltrexone on senile dementia of the Alzheimer type.
    Hyman BT; Eslinger PJ; Damasio AR
    J Neurol Neurosurg Psychiatry; 1985 Nov; 48(11):1169-71. PubMed ID: 3001233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naloxone in tardive dyskinesia.
    Blum I; Nisipeanu PF; Roberts E
    Psychopharmacology (Berl); 1987; 93(4):538. PubMed ID: 3124188
    [No Abstract]   [Full Text] [Related]  

  • 31. [Randomized double-blind clinical trial of moderate dosage naloxone in acute moderate and severe traumatic brain injury].
    Chen B; Liu YS
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):58-60. PubMed ID: 12575238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind placebo-controlled trial of naloxone on motor deficits in acute cerebrovascular disease.
    Perraro F; Tosolini G; Pertoldi F; Sbrojavacca R; Beorchia A; Bulfoni A; Del Fabbro L; Grassi L; Lestuzzi A; Mione V
    Lancet; 1984 Apr; 1(8382):915. PubMed ID: 6143225
    [No Abstract]   [Full Text] [Related]  

  • 34. length of clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Levy R
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():33. PubMed ID: 9305513
    [No Abstract]   [Full Text] [Related]  

  • 35. Naloxone fails to counteract heavy alcohol intoxication.
    Nuotto E; Palva ES; Lahdenranta U
    Lancet; 1983 Jul; 2(8342):167. PubMed ID: 6135014
    [No Abstract]   [Full Text] [Related]  

  • 36. Donepezil for Alzheimer's disease.
    Sparano N
    J Fam Pract; 1998 May; 46(5):356. PubMed ID: 9597987
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chronic non-malignant pain. Opioids are also suitable for long-term treatment].
    Wörz R
    MMW Fortschr Med; 2006 Apr; 148(17):47. PubMed ID: 16711488
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anti-dementia therapy pays at every stage of the disease. Patients with Alzheimer's disease stay all-day fit longer].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():113. PubMed ID: 14579507
    [No Abstract]   [Full Text] [Related]  

  • 39. Naloxone effectiveness on spontaneous and induced perceptive disorders in migraine.
    Sicuteri F; Boccuni M; Fanciullacci M; Gatto G
    Headache; 1983 Jul; 23(4):179-83. PubMed ID: 6350225
    [No Abstract]   [Full Text] [Related]  

  • 40. Naloxone for alcohol intoxication.
    Gillman MA; Lichtigfeld FJ
    Lancet; 1982 Sep; 2(8297):558. PubMed ID: 6125714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.